RGEN- Repligen Corporation
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 33 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $15.78M | - | |
| Dir | 91.8K | $14.64M | - | |
| CEO | 54.2K | $8.65M | - | |
| VP | 20.1K | $3.20M | - | |
| Other | 8.5K | $1.36M | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Loeillot Olivier | Chief Executive Officer | Sell | 3,832 | $140.00 | $536,480.00 | -6.6% | +11.9% | - | |
| Dec 17, 2025 | Dawes Karen A63 | Director | Sell | 275 | $161.00 | $44,275.00 | -0.3% | -24.0% | - | |
| Nov 25, 2025 | Loeillot Olivier | Chief Executive Officer | Sell | 7,041 | $170.00 | $1,196,970.00 | -16.4% | -21.0% | - | |
| Nov 18, 2025 | Bylund James70 | Chief Operating Officer | Sell | 2,191 | $151.21 | $331,301.11 | -9.2% | -11.5% | - | |
| Nov 13, 2025 | Hunt Anthony75 | Director | Sale+OE | 20,000 | $154.61 | $3,092,278.36 | -3.1% | -7.4% | - | |
| Nov 12, 2025 | Hunt Anthony75 | Director | Sale+OE | 25,000 | $156.88 | $3,921,939.67 | -4.3% | -9.5% | - | |
| Sep 10, 2025 | Hunt Anthony75 | Director | Sale+OE | 29,111 | $120.52 | $3,508,388.91 | -4.0% | +33.6% | - | |
| Aug 8, 2025 | Madaus Martin D72 | Director | Buy | 1,800 | $112.13 | $201,830.40 | New | +30.1% | - | |
| May 15, 2025 | Hunt Anthony75 | Director | Sell | 26,447 | $123.71 | $3,271,687.92 | -4.4% | +3.2% | -16.5% | |
| Mar 17, 2025 | Hunt Anthony75 | Director | Sale+OE | 26,756 | $152.51 | $4,080,663.26 | -2.8% | -17.5% | -21.9% |
Page 1Next →